ASIA News
It will use its fresh funds to complete a multi-site validation study across eight Asia-Pacific markets.
Dozee's sensor-based technology uses AI to track vital parameters.
It will be used to accelerate collaborations with pharmaceutical firms.
It will use its latest funds for its global expansion.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
The new funds will be used to support the rollout of its hypertension DTx app.
It is now preparing for a Series A fundraising round in the next six months.
There is a plan to expand its trial to more ambulances in the country to study its effectiveness.
It features more than 1,200 combinations of randomised simulated situations in a hospital ward.
Also, engineers from the University of Hong Kong have come up with a tiny biosensing platform for personalised health monitoring.